[PDF] Top 20 A rapid screening tool for fatigue impact in multiple sclerosis

... low fatigue (impact) within the MS group was most accurate in VAS_1, partic- ularly when MFIS was used to classify ...a tool to assess the impact of fatigue, which can be different from ... See full document

... Test administration-Having received the MAPI institute’s approval, the Persian version of the tool was developed. The final version of this questionnaire is registered and currently available on MAPI Research ... See full document

... between fatigue and IL6 levels Abbreviations: ACTH, adrenocorticotropic hormone; CAR, cortisol awakening response; CIS, clinical isolated syndrome; CLIP, corticotropin-like intermediate-lobe peptide; CSF, ... See full document

... Multiple Sclerosis (MS) is a debilitating disease caused by inflammation in the central nervous system resulting in demyelination (Paty, Noseworthy, & Ebers, ...with Multiple Sclerosis ... See full document

... questionnaires: Multiple Sclerosis Impact Profile, Modified Fatigue Impact Scale-5 items (MFIS-5), Hospital Anxiety and Depression Scale, Multiple Sclerosis Quality of ... See full document

... relapsing-remitting multiple sclerosis, namely glatiramer acetate and the β- interferons, provide a marked reduction in relapse rates and in MRI markers of disease activity ...ence fatigue symptoms ... See full document

... Mean fatigue scores measuring impact (MFIS) and severity (FSS) were found to follow similar patterns across the lev- els of physical disability on the PDDS (Figure ...1). Fatigue scores increased ... See full document

... symptomatic fatigue in individuals with multiple sclerosis ...Symptomatic fatigue was assessed using the Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale, and ... See full document

... [multiple sclerosis self-efficacy scale (MSSES)], impact on participation and autonomy [impact on participation and autonomy questionnaire (IPA)], HRQoL [multiple sclerosis ... See full document

... The Fatigue Severity Scale (FSS) is widely used to assess fatigue, not only in the context of multiple sclerosis-related fatigue, but also in many other medical ...without ... See full document

... palmar surface of hands at a consistent rhythm with a smooth, continuous motion that did not lose contact with the skin until completion of a described stroke. Hand-over-hand effleurage (E, hand-over-hand) was applied ... See full document

... Multiple Sclerosis (MS) is a demyelinating disorder of the central nervous system (CNS). It is the most neurologic disease among individuals of 20 – 45 years. A wide- spectrum of signs and symptoms might ... See full document

... Finally, some individuals experienced and expressed the loss of hope and hopelessness about their situation (14/47). Hopelessness was underpinned by the perceived limited value in trying to make changes because of the ... See full document

... model specifications, such as limited dependent variable mixture models or beta-based regression, which may have better accounted for the bi-modal nature of the EQ-5D data. There is some empirical evidence in sup- port ... See full document

... cause fatigue, must be considered in case history & physical ...pathologic fatigue and fatigue in healthy people that appears transiently; fatigue varies with increase of the amount of ... See full document

... Several scientifi c reports (Box et al 2003; Rieckman 2004; Heesen et al 2004) and our own experience show that it is useful to apply a structured approach, identify the initial crisis reaction, and separate it from the ... See full document

... In the general population it has been shown that men have a higher physical activity level than women [35]. Gender differences regarding factors associated with physical activity have also been shown, such as personal ... See full document

... Our findings highlight the necessity of thoroughly consid- ering the diagnostic goal of a walking test. It is known that the parameter of mean walking speed can be reliably derived from relatively short tests, e.g. the ... See full document

... Protein-tyrosine phosphatase SHP-1 may be implicated into immune system activation and inflammatory demyelination of MS patients [36]. MS patients were found to have a higher methylation level at the promoter 2 of SHP-1 ... See full document

... (clinical-radiological paradox). This “ time lag ” could be explained by an existing functional reserve and possible plasticity mechanisms. When these compensating mechan- isms are exhausted, however, a progressive ... See full document